Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AEZS

Aeterna Zentaris (AEZS)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AEZS
DateTimeSourceHeadlineSymbolCompany
09/25/20174:48PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
09/25/20174:30PMBusiness WireAeterna Zentaris Announces Appointment of Interim Chief Financial OfficerNASDAQ:AEZSAeterna Zentaris Inc
09/01/20174:52PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
09/01/20174:30PMBusiness WireAeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting OfficerNASDAQ:AEZSAeterna Zentaris Inc
08/11/20176:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
08/11/20176:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
08/10/20176:09PMBusiness WireAeterna Zentaris Reports Second Quarter 2017 Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
08/08/20174:40PMBusiness WireAeterna Zentaris Engages Advisors and Provides Update to ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
08/04/20175:00PMBusiness WireAeterna Zentaris to Announce Second Quarter 2017 Financial and Operating Results on August 10, 2017NASDAQ:AEZSAeterna Zentaris Inc
08/03/20171:26PMBusiness WireAeterna Zentaris Commences Legal Action Against David Dodd and Philip TheodoreNASDAQ:AEZSAeterna Zentaris Inc
07/24/20178:57AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
07/20/20175:00PMBusiness WireAeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEONASDAQ:AEZSAeterna Zentaris Inc
07/18/20175:00PMBusiness WireNDA for Macrilen™ for the Evaluation of Growth Hormone Deficiency in Adults Granted December 30, 2017 PDUFA DateNASDAQ:AEZSAeterna Zentaris Inc
06/30/20179:15AMBusiness WireAeterna Zentaris Resubmits NDA for Macrilen™ for the Evaluation of Growth Hormone Deficiency in AdultsNASDAQ:AEZSAeterna Zentaris Inc
06/09/20178:30AMBusiness WireAeterna Zentaris to Present at 2017 Marcum MicroCap ConferenceNASDAQ:AEZSAeterna Zentaris Inc
05/09/20175:17PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
05/09/20174:30PMBusiness WireAeterna Zentaris Announces Election of Directors at 2017 Shareholders' MeetingNASDAQ:AEZSAeterna Zentaris Inc
05/08/20175:20PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
05/08/20174:52PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
05/08/20174:30PMBusiness WireAeterna Zentaris Reports First Quarter 2017 Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
05/02/20178:30AMBusiness WireAeterna Zentaris to Announce First Quarter 2017 Financial and Operating Results on May 8, 2017NASDAQ:AEZSAeterna Zentaris Inc
05/01/20171:20PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
05/01/20178:00AMBusiness WireAeterna Zentaris Announces that ZoptEC Phase 3 Clinical Study of Zoptrex™ Did Not Achieve its Primary EndpointNASDAQ:AEZSAeterna Zentaris Inc
04/28/20175:00PMBusiness WireAeterna Zentaris to Announce Top-Line Results of the ZoptEC Phase 3 Clinical Study of Zoptrex™NASDAQ:AEZSAeterna Zentaris Inc
04/28/20176:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
04/28/20176:06AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AEZSAeterna Zentaris Inc
04/28/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AEZSAeterna Zentaris Inc
04/27/20178:15PMBusiness WireAeterna Zentaris Announces Replacement At the Market Issuance ProgramNASDAQ:AEZSAeterna Zentaris Inc
04/24/20174:47PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:AEZSAeterna Zentaris Inc
04/14/20176:03AMEdgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:AEZSAeterna Zentaris Inc
 Showing the most relevant articles for your search:NASDAQ:AEZS